Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target

Naomi Pode‐Shakked(Edmond and Lily Safra Children's Hospital), Orit Harari‐Steinberg(Sheba Medical Center), Y. Haberman-Ziv(Sheba Medical Center), Eithan Rom‐Gross(Hebrew University of Jerusalem), S Bahar(Tel Aviv University), Dashne Shamall Omer(Tel Aviv University), Sally Metsuyanim(Edmond and Lily Safra Children's Hospital), Ella Buzhor(Tel Aviv University), Jasmin Jacob–Hirsch(Sheba Medical Center), Ronald S. Goldstein(Bar-Ilan University), Michal Mark‐Danieli(Sheba Medical Center), Benjamin Dekel(Edmond and Lily Safra Children's Hospital)
Oncogene
January 17, 2011
10.1038/onc.2010.549
Cited by 97

Abstract

Related Papers

Identification of human brain tumour initiating cells
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke et al.|Nature|2004|7.4k
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al.|Nature|2006|6.4k
Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells
Michael F. Clarke, John E. Dick, Peter B. Dirks et al.|Cancer Research|2006|3.1k
WNT and β-catenin signalling: diseases and therapies
Randall T. Moon, Aimee D. Kohn, G. Ferrari et al.|Nature Reviews Genetics|2004|1.8k
Caught up in a Wnt storm: Wnt signaling in cancer
Rachel H. Giles, Johan H. van Es, Hans Clevers|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2003|1.5k